ANDREW FISH — Lobbyist Profile | Poliscope

ANDREW FISH

Reported covered position: N/A

Filings

Clients

Firms

Years active

2006–2010

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	15	2006–2010

Lobbying firms

Firm	Filings	Years
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	15	2006–2010

Bills explicitly cited in this lobbyist’s assigned issues (100)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1259

Dextromethorphan Distribution Act of 2009

Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Open original LDA filing ↗

Cited source text

HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

H.R. 1259

Dextromethorphan Distribution Act of 2009

Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Open original LDA filing ↗

Cited source text

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

Original LDA source filings (15)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2010 · third_quarter · Q3

Firm income: —Client expense: $736,734Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

ALC

Alcohol and Drug Abuse

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

PHA

Pharmacy

Issues related to methamphetamine precursor chemicals HR 759, HR 5740, S 882, S 3690 - regarding the manufacturing and importation of OTC drugs and the mandatory recall authority of the FDA.

FOO

Source: Senate LDA

Show 11 more original filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2009 · third_quarter · Q3

Firm income: —Client expense: $225,686Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CSP

Consumer Issues/Safety/Products

HR 2749 - Food Safety Enhancement Act of 2009 HR 759 & S 556 - Import Safety

ALC

Alcohol and Drug Abuse

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse

TAX

Taxation/Internal Revenue Code

HR 3200 - America's Healthy Choice Act Senate Health Care Reform - Americas Healthy Future Act

Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2009 · second_quarter · Q2

Firm income: —Client expense: $258,443Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

TAX

Taxation/Internal Revenue Code

Financing Comprehensive Health Reform

BUD

Budget/Appropriations

HR 2997, Funding for the Food and Drug Administration HR 2847, Commerce, Justice & Science Appropriations

HCR

Health Issues

Financing Comprehensive Health Reform The Affordable Health Choices Act America's Affordable Health Choices Act

ALC

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2009 · first_quarter · Q1

Firm income: —Client expense: $256,057Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

ALC

Alcohol and Drug Abuse

HR 1259, Dextromethorphan Abuse S 256, Methamphetamine

CSP

Consumer Issues/Safety/Products

Import Safety, HR 759 Consumer Product Safety Improvement Act

HCR

Health Issues

Regulation of Over-the-Counter Drugs, Import Safety HR 759

BUD

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2008 · fourth_quarter · Q4

Firm income: —Client expense: $65,235Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

CSP

Consumer Issues/Safety/Products

Import Safety, S. 3409 Consumer Product Safety Improvement Act, H.R. 4040

TAX

Taxation/Internal Revenue Code

Over-the-Counter Tax Deductibility, HR 3109

ALC

Alcohol and Drug Abuse

Dextromethorphan Abuse, Methampehtamine S. 2237, S. 3374, S. 1378, S 1276, HR 970

HCR

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2008 · third_quarter · Q3

Firm income: —Client expense: $116,217Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

HCR

Health Issues

Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151 Direct to Consumer Advertising of Drugs

ALC

Alcohol and Drug Abuse

Dextromethorphan Abuse, Methamphetamine S. 2237, S. 2274, S. 1378, HR 970, S. 1276

BUD

Budget/Appropriations

Additional Funding for the Food and Drug Administration

CSP

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2008 · first_quarter · 1A

Firm income: —Client expense: $110,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

BUD

Budget/Appropriations

Additional Funding for the Food and Drug Administration.

ALC

Alcohol and Drug Abuse

Dextromethorphan Abuse S. 2237, S. 2274, S. 1378, H.R. 970

COM

Communications/Broadcasting/Radio/TV

S. 2311, H.R. 4083. Issues concerning advertising of over-the-counter medicines.

HCR

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2008 · second_quarter · Q2

Firm income: —Client expense: $150,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

TAX

Taxation/Internal Revenue Code

Over-the-Counter Drug Tax Deductibility, HR 3109

HCR

Health Issues

Pediatric Cough and Cold Medicines; Regulation and Advertising of OTC's, H.R. 4083 and S. 2311 H.R. 6151 Direct to Consumer Advertising of Drugs

BUD

Budget/Appropriations

Additional Funding for the Food and Drug Administration

ALC

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2008 · first_quarter · Q1

Firm income: —Client expense: $110,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

TAX

Taxation/Internal Revenue Code

Over-the-counter Drug Tax Deductibility

COM

Communications/Broadcasting/Radio/TV

S. 2311, H.R. 4083. Issues concerning advertising of over-the-counter medicines.

CSP

Consumer Issues/Safety/Products

Import Safety; H.R. 3610

BUD

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2007 · year_end · YY

Firm income: —Client expense: $244,322Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

LAW

Law Enforcement/Crime/Criminal Justice

Organized Retail Crime

HCR

Health Issues

* HR 3109 -- Oral Healthcare Costs S 2311, HR 4083 -- Regulation of over-the-counter drugs. HR 3109 -- Oral Healthcare Costs

BUD

Budget/Appropriations

S. 1859-- FDA Appropriations.

FOO

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2007 · mid_year · MM

Firm income: —Client expense: $200,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

HCR

Health Issues

Prescription Drug User Fee Amendments of 2007 S 1082, HR 2900 Regulation of non-prescription drugs

TAX

Taxation/Internal Revenue Code

Tax Deductibility of Non Prescription Drugs

ALC

Alcohol and Drug Abuse

Dextromethorphan Distribution Act of 2007 - HR 970, S 1378. National Medicine Abuse Awareness Month S Res. 225.

LAW

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

2006 · year_end · YY

Firm income: —Client expense: $70,000Open original LDA filing ↗

Assigned issues and filing targets (6 issues)

ALC

Alcohol and Drug Abuse

Dextromethorphan Distribution Act of 2006 - H.R 5280

TAX

Taxation/Internal Revenue Code

OTC Medicine Tax Fairness Act of 2005 - H.R. 3428, S. 1514

MED

Medical/Disease Research/Clinical Labs

Dietary Supplement and Nonprescription Drug Consumer Protection Act - S. 3546 (OTC provisions)

BUD